Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013067 |
---|---|
Receipt number | R000015061 |
Scientific Title | Phase I/II trial of subcutaneous bortezomib plus lenalidomide combined with dexamethasone combination therapy for relapsed or refractory multiple myeloma patients |
Date of disclosure of the study information | 2014/02/08 |
Last modified on | 2019/03/09 10:51:49 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/02/04 12:41:43 | ||
2 | Update | 2015/10/21 11:08:11 | Recruitment status |
|
3 | Update | 2019/03/09 10:51:49 | Recruitment status |